ACP
Acuta Capital Partners’s Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 NUVB.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.5K | Hold |
90,832
| – | – | 0.03% | 28 |
|
|
2025
Q1 | $17.5K | Hold |
90,832
| – | – | 0.02% | 33 |
|
|
2024
Q4 | $20.9K | Hold |
90,832
| – | – | 0.02% | 39 |
|
|
2024
Q3 | $8.89K | Hold |
90,832
| – | – | 0.01% | 41 |
|
|
2024
Q2 | $14.5K | Hold |
90,832
| – | – | 0.01% | 32 |
|
|
2024
Q1 | $27.5K | Hold |
90,832
| – | – | 0.02% | 33 |
|
|
2023
Q4 | $5.45K | Hold |
90,832
| – | – | ﹤0.01% | 38 |
|
|
2023
Q3 | $9.08K | Hold |
90,832
| – | – | 0.01% | 42 |
|
|
2023
Q2 | $15K | Hold |
90,832
| – | – | 0.01% | 35 |
|
|
2023
Q1 | $10.9K | Hold |
90,832
| – | – | 0.01% | 33 |
|
|
2022
Q4 | $13.1K | Hold |
90,832
| – | – | 0.01% | 34 |
|
|
2022
Q3 | $15K | Hold |
90,832
| – | – | 0.01% | 45 |
|
|
2022
Q2 | $25K | Buy |
+90,832
| New | +$25K | 0.01% | 41 |
|
|
2021
Q4 | – | Sell |
-90,832
| Closed | -$242K | – | 47 |
|
|
2021
Q3 | $242K | Hold |
90,832
| – | – | 0.09% | 46 |
|
|
2021
Q2 | $236K | Sell |
90,832
-2,500
| -3% | -$6.5K | 0.09% | 37 |
|
|
2021
Q1 | $249K | Buy |
+93,332
| New | +$249K | 0.09% | 46 |
|